Yuxin Chen
Shanghai, 200072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.
Journal: Cell death & disease
Published: April 07, 2019
High glucose stimulates proliferative capacity of liver cancer cells possibly via O-GlcNAcylation-dependent transcriptional regulation of GJC1.
Journal: Journal of cellular physiology
Published: November 09, 2017
TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy.
Journal: Cell reports
Published: May 29, 2017
Angiopoietin-2 (Ang-2) is a useful serum tumor marker for liver cancer in the Chinese population.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: April 21, 2017
NRAGE induces β-catenin/Arm O-GlcNAcylation and negatively regulates Wnt signaling.
Journal: Biochemical and biophysical research communications
Published: March 06, 2017
The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis.
Journal: Nature communications
Published: August 21, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026